These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 15025524)

  • 1. Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides.
    Moulton HM; Nelson MH; Hatlevig SA; Reddy MT; Iversen PL
    Bioconjug Chem; 2004; 15(2):290-9. PubMed ID: 15025524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity.
    Nelson MH; Stein DA; Kroeker AD; Hatlevig SA; Iversen PL; Moulton HM
    Bioconjug Chem; 2005; 16(4):959-66. PubMed ID: 16029037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live-cell analysis of cell penetration ability and toxicity of oligo-arginines.
    Tünnemann G; Ter-Avetisyan G; Martin RM; Stöckl M; Herrmann A; Cardoso MC
    J Pept Sci; 2008 Apr; 14(4):469-76. PubMed ID: 18069724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
    Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
    Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo.
    Moulton HM; Fletcher S; Neuman BW; McClorey G; Stein DA; Abes S; Wilton SD; Buchmeier MJ; Lebleu B; Iversen PL
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):826-8. PubMed ID: 17635157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense peptide-phosphorodiamidate morpholino oligomer conjugate: dose-response in mice infected with Escherichia coli.
    Tilley LD; Mellbye BL; Puckett SE; Iversen PL; Geller BL
    J Antimicrob Chemother; 2007 Jan; 59(1):66-73. PubMed ID: 17079242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate.
    Amantana A; Moulton HM; Cate ML; Reddy MT; Whitehead T; Hassinger JN; Youngblood DS; Iversen PL
    Bioconjug Chem; 2007; 18(4):1325-31. PubMed ID: 17583927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV Tat peptide enhances cellular delivery of antisense morpholino oligomers.
    Moulton HM; Hase MC; Smith KM; Iversen PL
    Antisense Nucleic Acid Drug Dev; 2003 Feb; 13(1):31-43. PubMed ID: 12691534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.
    Abes S; Moulton HM; Clair P; Prevot P; Youngblood DS; Wu RP; Iversen PL; Lebleu B
    J Control Release; 2006 Dec; 116(3):304-13. PubMed ID: 17097177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved cellular activity of antisense peptide nucleic acids by conjugation to a cationic peptide-lipid (CatLip) domain.
    Koppelhus U; Shiraishi T; Zachar V; Pankratova S; Nielsen PE
    Bioconjug Chem; 2008 Aug; 19(8):1526-34. PubMed ID: 18646838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense phosphorodiamidate morpholino oligomer inhibits viability of Escherichia coli in pure culture and in mouse peritonitis.
    Geller BL; Deere J; Tilley L; Iversen PL
    J Antimicrob Chemother; 2005 Jun; 55(6):983-8. PubMed ID: 15872045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A concise method for the preparation of peptide and arginine-rich peptide-conjugated antisense oligonucleotide.
    Chen CP; Zhang LR; Peng YF; Wang XB; Wang SQ; Zhang LH
    Bioconjug Chem; 2003; 14(3):532-8. PubMed ID: 12757376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense phosphorodiamidate morpholino oligomer length and target position effects on gene-specific inhibition in Escherichia coli.
    Deere J; Iversen P; Geller BL
    Antimicrob Agents Chemother; 2005 Jan; 49(1):249-55. PubMed ID: 15616302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simplified preparation via streptavidin of antisense oligomers/carriers nanoparticles showing improved cellular delivery in culture.
    Wang Y; Nakamura K; Liu X; Kitamura N; Kubo A; Hnatowich DJ
    Bioconjug Chem; 2007; 18(4):1338-43. PubMed ID: 17605463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular delivery strategies for antisense phosphorodiamidate morpholino oligomers.
    Ghosh C; Iversen PL
    Antisense Nucleic Acid Drug Dev; 2000 Aug; 10(4):263-74. PubMed ID: 10984120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine-rich cell-penetrating peptides facilitate delivery of antisense oligomers into murine leukocytes and alter pre-mRNA splicing.
    Marshall NB; Oda SK; London CA; Moulton HM; Iversen PL; Kerkvliet NI; Mourich DV
    J Immunol Methods; 2007 Aug; 325(1-2):114-26. PubMed ID: 17673254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-assisted delivery of steric-blocking antisense oligomers.
    Moulton HM; Moulton JD
    Curr Opin Mol Ther; 2003 Apr; 5(2):123-32. PubMed ID: 12772501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-step process for screening antisense compounds for efficacy: gene target IL-12Rb2.
    Marshall NB; Hauck LL; Mourich DV
    Methods Mol Biol; 2011; 764():153-68. PubMed ID: 21748639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor down-regulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers.
    Ko YJ; Devi GR; London CA; Kayas A; Reddy MT; Iversen PL; Bubley GJ; Balk SP
    J Urol; 2004 Sep; 172(3):1140-4. PubMed ID: 15311058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the impact of valency on the routing of arginine-rich peptides into eukaryotic cells.
    Kawamura KS; Sung M; Bolewska-Pedyczak E; Gariépy J
    Biochemistry; 2006 Jan; 45(4):1116-27. PubMed ID: 16430208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.